| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |